CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Update

CanSino Biologics Inc. (OTCMKTS:CASBF) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totalling 20,000 shares, a growth of 35.1% from the November 30th total of 14,800 shares. Based on an average trading volume of 400 shares, the days-to-cover ratio is currently 50.0 days.

CanSino Biologics Stock Performance

CASBF traded up C$0.25 during midday trading on Monday, reaching C$4.00. 465 shares of the company’s stock were exchanged, compared to its average volume of 1,363. The business’s 50-day moving average price is C$3.86 and its 200 day moving average price is C$3.02. CanSino Biologics has a 1-year low of C$1.86 and a 1-year high of C$4.35.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.